title: The case against BRCA 1 and 2 testing.
authors.affiliation: Department of Surgery, University of California, San Francisco-East Bay, Oakland, CA 94602, USA. Cheryl.Lin@ucsfmedctr.org
authors.forename: Cheryl
authors.initials: C
authors.lastname: Lin
authors.forename: Tina
authors.initials: T
authors.lastname: Sasaki
authors.forename: Aaron
authors.initials: A
authors.lastname: Strumwasser
authors.forename: Alden
authors.initials: A
authors.lastname: Harken
mesh_terms: D019313:BRCA1 Protein / Q000235:genetics*; D024682:BRCA2 Protein / Q000235:genetics*; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000235:genetics; D018270:Carcinoma, Ductal, Breast / Q000175:diagnosis* / Q000235:genetics; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000175:diagnosis* / Q000235:genetics; D005260:Female; D020022:Genetic Predisposition to Disease / Q000235:genetics; D005820:Genetic Testing / Q000639:trends*; D005838:Genotype; D006801:Humans; D009154:Mutation / Q000235:genetics; D010641:Phenotype; D012307:Risk Factors
chemical_list: D019313:BRCA1 Protein; D024682:BRCA2 Protein